Automatic Website Traffic RSS

High-efficacy therapy found to cut disability progression in pediatric MS study

Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue ... read more

Immune signatures may predict MS course, treatment response

Three distinct immune signatures in the blood could be linked to the course MS takes in patients, and how well they respond to treatment. read more

Groundbreaking research identifies three distinct multiple sclerosis endophenotypes for personalized treatment

An international team led by the University of Münster and the University Hospital of Münster, Germany, discovered three distinct immunological endophenotypes in multiple sclerosis (MS) patients, ... read more

Multiple Sclerosis Research News

Researchers have discovered that a protein called Snail ... Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise ... read more

Exploring Adverse Outcomes of Early Prognostication Following Initial Signs of MS

The following is a summary of “Early prediction of unfavorable evolution after a first clinical episode suggestive of multiple sclerosis: the EUMUS score,” published in the March 2024 issue of ... read more

Kessler scientists using $700K grant to study primary fatigue in MS

The National Multiple Sclerosis Society granted $722,602 to Kessler Foundation scientists to study brain networks linked to fatigue in MS. read more

Research offers insight into future understanding of MS and its treatments

MS is a chronic neurological disease with no known cure. It affects approximately three million people worldwide and is the second leading cause of disability in young adults. There is a pressing need ... read more

Multiple sclerosis: subtype discovery opens new ways for personalized therapy

An international team of researchers, led by the University of Münster and Department of Neurology at the University Hospital of Münster, Germany, in collaboration with the German Competence Network ... read more

Buy Rating Affirmed for Kyverna Therapeutics on Promising Early-Stage KYV-101 Results for MS Treatment

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on KYTX stock, giving a Buy rating on March 26. Thomas Smith has ... read more

Gavaskar shreds MI for giving MS Dhoni 'beneficiary' treatment: 'They thought it's MSD's last game in Mumbai so…'

I f the IPL 2024 encounter against Mumbai Indians was MS Dhoni's last match at the Wankhede Stadium, what a way it was to go out. At a venue where Dhoni achieved the greatest mome ... read more

Personalised blood cancer treatment approved for routine rollout on the NHS

A charity said the decision offers a ‘ray of hope’ to those aged 25 and under with B-cell acute lymphoblastic leukaemia. read more

Trinity research offers insight into the future understanding of MS and its treatments

Researchers at Trinity College Dublin have developed a new and unique blood test to measure the immune response to the Epstein Barr Virus (EBV) which is the leading risk factor for developing multiple ... read more